Dr. Warshauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
Ste 550
San Francisco, CA 94143Phone+1 415-353-2350Fax+1 415-353-2337
Summary
- Jeremy Warshauer, MD is an experienced endocrinologist based in San Francisco, CA, with a particular focus on diabetes and lipid metabolism. He pursued his education and residency at the University of Texas Southwestern Medical School and later completed his fellowship in Endocrinology, Diabetes, and Metabolism at the University of California, San Francisco. Dr. Warshauer has published several widely-cited research articles in reputable journals such as The Journal of Experimental Medicine, Cell Metabolism, JAMA Internal Medicine, and Nature Medicine, reflecting his significant contributions to the field of endocrinology. He has also been recognized with a post-doctoral fellowship from the Juvenile Diabetes Research Foundation (JDRF).
Education & Training
- University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2019
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2013 - 2016
- University of Texas Southwestern Medical SchoolClass of 2013
- HarvardAB, Chemistry, 2004 - 2008
Certifications & Licensure
- CA State Medical License 2016 - 2025
- TX State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Post-doctoral fellowship JDRF
Publications & Presentations
PubMed
- 31 citationsA human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.Jeremy T. Warshauer, Julia A. Belk, Alice Y. Chan, Jiaxi Wang, Alexander R Gupta
The Journal of Experimental Medicine. 2021-08-02 - 123 citationsNew Frontiers in the Treatment of Type 1 DiabetesJeremy T. Warshauer, Jeffrey A. Bluestone, Mark S. Anderson
Cell Metabolism. 2020-01-07 - New Frontiers in the Treatment of Type 1 Diabetes.Jeremy T Warshauer, Jeffrey A Bluestone, Mark S Anderson
Cell metabolism. 2019-12-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: